Activation of AMPK-SIRT3 signaling is chondroprotective by preserving mitochondrial DNA integrity and function

In osteoarthritis (OA), articular chondrocytes manifest mitochondrial damage, including mitochondrial DNA 4977-bp (mtDNA4977) deletion that impairs mitochondrial function. OA chondrocytes have decreased activity of AMPK, an energy biosensor that promotes mitochondrial biogenesis. Here, we tested if...

Full description

Saved in:
Bibliographic Details
Published inOsteoarthritis and cartilage Vol. 26; no. 11; pp. 1539 - 1550
Main Authors Chen, L.-Y., Wang, Y., Terkeltaub, R., Liu-Bryan, R.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.11.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In osteoarthritis (OA), articular chondrocytes manifest mitochondrial damage, including mitochondrial DNA 4977-bp (mtDNA4977) deletion that impairs mitochondrial function. OA chondrocytes have decreased activity of AMPK, an energy biosensor that promotes mitochondrial biogenesis. Here, we tested if pharmacologic AMPK activation, via downstream activation of predominately mitochondrially localized sirtuin 3 (SIRT3), reverses existing decreases in mitochondrial DNA (mtDNA) integrity and function in human OA chondrocytes and limits mouse knee OA development. We assessed mtDNA integrity and function including the common mtDNA4977 deletion and mtDNA content, mitochondrial reactive oxygen species (mtROS) generation, oxygen consumption and intracellular ATP levels. Phosphorylation of AMPKα, expression and activity of SIRT3, acetylation and expression of the mitochondrial antioxidant enzyme SOD2 and DNA repair enzyme 8-oxoguanine glycosylase (OGG1), and expression of subunits of mitochondrial respiratory complexes were examined. We assessed effect of pharmacologic activation of AMPK on age-related spontaneous mouse knee OA. The mtDNA4977 deletion was detected in both OA chondrocytes and menadione-treated normal chondrocytes, associated with increased mtROS, decreased SIRT3, and increased acetylation of SOD2 and OGG1. AMPKα1 deficient chondrocytes exhibited significantly reduced SIRT3 activity. AMPK pharmacologic activation attenuated existing mtDNA4977 deletion and improved mitochondrial functions in OA chondrocytes via SIRT3 by reducing acetylation and increasing expression of SOD2 and OGG1, and limited aging-associated mouse knee OA development and progression. AMPK activation, via SIRT3, limits oxidative stress and improves mtDNA integrity and function in OA chondrocytes. These effects likely contribute to chondroprotective effects of AMPK activity.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Analysis and interpretation of data: Chen, Wang, Terkeltaub, Liu-Bryan
Conception and design: Chen, Wang, Terkeltaub, Liu-Bryan
Collection and assembly of data: Chen, Wang, Liu-Bryan
Obtaining funding: Liu-Bryan, Terkeltaub
Author Contributions
All authors were involved in drafting and revision of the manuscript and all authors approved the final version to be published. Dr Liu-Bryan had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
ISSN:1063-4584
1522-9653
1522-9653
DOI:10.1016/j.joca.2018.07.004